{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":33,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":33,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"8cebc2dd487b","filters":{"venue":"Current Hematologic Malignancy Reports"}},"results":[{"id":"W2287622513","doi":"10.1007/s11899-016-0313-6","title":"Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CARE Canada","funders":"National Cancer Institute","keywords":"Medicine; Young adult; Cancer; Breast cancer; Incidence (geometry); Population; Social media; Oncology; Internal medicine; Pediatrics; Gerontology","retraction":null,"screen_n_in":null,"score":{"opus":0.05691916317588371,"gpt":0.3565261188265781,"spread":0.2996069556506945,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006353747,0.0008539365,0.003720364,0.0001283054,0.0002489359,0.00005845146,0.0001406152,0.0003552886,0.00007591629],"category_scores_gemma":[0.0005638796,0.0003973155,0.0004260107,0.0002328046,0.0008406987,0.0000687279,0.0002555176,0.0006793744,0.000006271532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001564777,"about_ca_system_score_gemma":0.0006507966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005922029,"about_ca_topic_score_gemma":0.0001166929,"domain_scores_codex":[0.9951337,0.0004002569,0.00178302,0.001176947,0.0009184629,0.0005876451],"domain_scores_gemma":[0.9961275,0.000360123,0.002193303,0.00073774,0.0002840844,0.0002972346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001423355,0.0002470292,0.003900489,0.06502989,0.0004456142,0.001476338,0.002208699,3.692915e-9,5.301861e-8,0.002040054,0.008030033,0.9164795],"study_design_scores_gemma":[0.002394387,0.0001083735,0.0004397011,0.1952071,0.003216083,0.02501801,0.0002019034,4.189572e-7,0.000003601011,0.0008629622,0.7715134,0.001034059],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009058152,0.992946,0.0000181443,0.001243932,0.001695267,0.002698459,0.000058874,0.0001154114,0.0003180411],"genre_scores_gemma":[0.003385193,0.9947018,0.00002894869,0.0001879015,0.0006359751,0.0008594985,0.00007054955,0.00007797567,0.00005214374],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9154454,"threshold_uncertainty_score":0.9998479,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2409124043","doi":"10.1007/s11899-016-0333-2","title":"Value Based Care and Patient-Centered Care: Divergent or Complementary?","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Value (mathematics); Health care; Quality (philosophy); Incentive; Medicine; Preference; Payment; Value-Based Purchasing; Reimbursement; Nursing; Family medicine; Business; Computer science; Economics; Microeconomics","retraction":null,"screen_n_in":null,"score":{"opus":0.09273398251352287,"gpt":0.3165248023298274,"spread":0.2237908198163046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002025014,0.0009069112,0.003446958,0.0003956618,0.0002366464,0.0001227678,0.0003602352,0.000380501,0.001098814],"category_scores_gemma":[0.0001892741,0.0006948292,0.0007958192,0.0002307884,0.0001555741,0.0002351749,0.0003516721,0.0003084353,0.000230286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006476768,"about_ca_system_score_gemma":0.0003226405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004735898,"about_ca_topic_score_gemma":0.00001400516,"domain_scores_codex":[0.9945137,0.00005974991,0.002944712,0.001580353,0.00009835271,0.0008031257],"domain_scores_gemma":[0.9951411,0.0001001469,0.003327704,0.001052393,0.0001100863,0.0002685632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000175193,0.0001140332,0.00448679,0.02747218,0.0001476083,0.0005620458,0.0003769947,4.239867e-7,1.288243e-8,0.009962417,0.005857824,0.9510022],"study_design_scores_gemma":[0.0004421544,0.0001763874,0.00003244219,0.01769696,0.0001271226,0.0002955654,0.00006370029,0.000001495102,0.000002081295,0.001548936,0.9786791,0.0009340649],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001418131,0.9877734,0.000212069,0.00003713243,0.004315269,0.00178383,0.002004193,0.00009241602,0.003639889],"genre_scores_gemma":[0.002616667,0.9957335,0.0002472331,0.00009494166,0.0001652795,0.0003713518,0.0006110977,0.00009007101,0.00006985905],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9728213,"threshold_uncertainty_score":0.9998143,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024403341","doi":"10.1007/s11899-013-0163-4","title":"Hodgkin Lymphoma in Pregnancy","year":2013,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Pregnancy; Vinblastine; Lymphoma; Intensive care medicine; Disease; Hodgkin lymphoma; Chemotherapy; Internal medicine; Pediatrics; Obstetrics","retraction":null,"screen_n_in":null,"score":{"opus":0.03098564659025149,"gpt":0.3045995390588377,"spread":0.2736138924685862,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001197379,0.0002764654,0.0006359429,0.0001826157,0.00004471635,0.0000298245,0.00008204772,0.000141714,0.001295845],"category_scores_gemma":[0.0001471403,0.0002120857,0.0001734393,0.0003502152,0.00007509685,0.0001488737,0.00007159571,0.0001618452,0.0001548291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001293356,"about_ca_system_score_gemma":0.0001623033,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002236453,"about_ca_topic_score_gemma":0.00001654498,"domain_scores_codex":[0.9977084,0.00003337046,0.0008501238,0.0005847096,0.0003136232,0.000509817],"domain_scores_gemma":[0.9987001,0.00003211962,0.0003194331,0.0006380373,0.0001038906,0.0002063548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000012082,0.0005423696,0.8621181,0.0004672445,0.00001676526,0.002421865,0.000147776,6.651547e-7,0.0002711444,0.0005394743,0.005504728,0.1279578],"study_design_scores_gemma":[0.002230806,0.0002463549,0.9321361,0.005936385,0.00008448528,0.008786757,0.0001352155,0.00008956693,0.004963141,0.009708955,0.03491125,0.0007710414],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.963698,0.02717198,0.00006938735,0.0003137189,0.001207852,0.001358628,0.000002066992,0.0001663922,0.006011921],"genre_scores_gemma":[0.9975948,0.001235936,0.0001820366,0.00007118144,0.00006318689,0.000411965,0.00002759986,0.00002471785,0.0003885724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1271868,"threshold_uncertainty_score":0.9996171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1946581526","doi":"10.1007/s11899-015-0286-x","title":"Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":51,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Aurora Research Institute; American Association for Cancer Research","keywords":"Social media; Microblogging; Workflow; Public relations; Internet privacy; Hematologist; Health care; Medicine; Medical education; World Wide Web; Computer science; Internal medicine; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.4678624804527811,"gpt":0.5264026431069447,"spread":0.05854016265416362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.008693935,0.0005946799,0.002567715,0.0001157238,0.002382572,0.0002438903,0.000584613,0.0007760093,0.00002660363],"category_scores_gemma":[0.03535924,0.000316535,0.0005414609,0.0006504477,0.001813409,0.0001805904,0.0001856043,0.0009891063,0.00001270055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005022519,"about_ca_system_score_gemma":0.004507155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007210987,"about_ca_topic_score_gemma":0.0005687604,"domain_scores_codex":[0.9927387,0.002233037,0.002019076,0.0009343147,0.001040084,0.001034802],"domain_scores_gemma":[0.9740028,0.02040781,0.003875738,0.0006811377,0.0007366337,0.0002959086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001866939,0.00008273957,0.0003929866,0.02536936,0.00008880107,0.0000475974,0.03845412,1.861996e-8,1.295366e-9,0.04998305,0.0289048,0.8566579],"study_design_scores_gemma":[0.000222617,0.00001149391,0.000009147038,0.003901779,0.0007428098,0.0003941535,0.005002527,8.629038e-7,6.333309e-8,0.01960693,0.9697535,0.0003541123],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002358845,0.9486113,0.00004816282,0.02084451,0.01668632,0.01333987,0.00001161111,0.0001521237,0.0002825204],"genre_scores_gemma":[0.0006590991,0.9775695,0.0001066727,0.0001652309,0.003458102,0.01785658,0.00007410988,0.00006070039,0.00005000736],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9408487,"threshold_uncertainty_score":0.9999287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2801721440","doi":"10.1007/s11899-018-0449-7","title":"Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Imatinib; Oncology; Disease; Tyrosine kinase; Imatinib mesylate; Tyrosine-kinase inhibitor; Internal medicine; Myeloid leukemia; Toxicity; Pharmacology; Intensive care medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.07998761122677826,"gpt":0.4216340902875697,"spread":0.3416464790607914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000618639,0.001149988,0.004421451,0.0004622164,0.0001253055,0.0000555824,0.0003091529,0.0005404822,0.000148856],"category_scores_gemma":[0.0004287186,0.0006400202,0.001493682,0.0006364395,0.0002663317,0.0001104575,0.0000790292,0.0003053754,0.00001738025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002312282,"about_ca_system_score_gemma":0.003308479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002568282,"about_ca_topic_score_gemma":0.00005534336,"domain_scores_codex":[0.9936889,0.0001823548,0.003346301,0.001336576,0.0006482787,0.0007975989],"domain_scores_gemma":[0.9941503,0.0009516115,0.002589106,0.001941061,0.0002257978,0.0001420788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001140621,0.005416133,0.0001622694,0.03110781,0.0003098198,0.004231449,0.0002627292,0.000001187937,0.000001154269,0.0002844291,0.003458973,0.95465],"study_design_scores_gemma":[0.003863148,0.003311185,0.000006553696,0.1040403,0.002911029,0.004743894,0.00009474147,0.00003770668,0.00004192026,0.001424442,0.8789709,0.000554223],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002819352,0.9866053,0.0004377486,0.00002087088,0.001853809,0.00787125,0.0001247006,0.00008386893,0.000183106],"genre_scores_gemma":[0.008243018,0.9866268,0.0009605885,0.000008559495,0.0007610067,0.002501038,0.0007533219,0.0001024686,0.00004318358],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9540958,"threshold_uncertainty_score":0.9996051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282946191","doi":"10.1007/s11899-022-00663-7","title":"Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Canadian Institutes of Health Research","keywords":"CHEK2; Germline; Myeloid leukemia; Myeloid; Germline mutation; Biology; Chronic lymphocytic leukemia; Leukemia; Cancer research; Immunology; Genetics; Mutation; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0919673839579153,"gpt":0.3717642047439677,"spread":0.2797968207860523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001639693,0.001103815,0.004731006,0.0007744614,0.0001890997,0.00007984243,0.0002764045,0.0005996699,0.001284588],"category_scores_gemma":[0.0009002374,0.0008512886,0.0004450375,0.0009957631,0.0003995703,0.0001116767,0.000990537,0.001694432,0.00003625103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005017669,"about_ca_system_score_gemma":0.00120197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003611916,"about_ca_topic_score_gemma":0.000006487584,"domain_scores_codex":[0.9932408,0.0004204214,0.002465931,0.001915439,0.0008494781,0.001107905],"domain_scores_gemma":[0.9964081,0.0004380398,0.001250239,0.001363329,0.00008291609,0.0004573891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007088512,0.001040525,0.01631631,0.2265632,0.0004766575,0.05414483,0.0006864679,1.763155e-7,0.00001152154,0.002895332,0.005116692,0.6926774],"study_design_scores_gemma":[0.0005637332,0.00012521,0.0002074125,0.02397299,0.0006303378,0.08167792,0.00004830643,0.000007959788,0.000006334377,0.0007193826,0.8912932,0.0007472298],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002796591,0.9914899,0.00001087831,0.0000920216,0.0005917481,0.003238734,0.00005000495,0.0001598187,0.001570245],"genre_scores_gemma":[0.0004833259,0.9965495,0.0002700978,0.00009234695,0.0001359312,0.001157992,0.0001876203,0.0001624825,0.0009607213],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8861765,"threshold_uncertainty_score":0.9996284,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1944062703","doi":"10.1007/s11899-015-0287-9","title":"Social Media and Myeloproliferative Neoplasms (MPN)—Focus on Twitter and the Development of a Disease-specific Community: #MPNSM","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Texas MD Anderson Cancer Center; Incyte; National Cancer Institute; Gilead Sciences","keywords":"Social media; Medicine; Public relations; Citation; Focus group; Health care; Internet privacy; Political science; World Wide Web; Business; Computer science; Marketing","retraction":null,"screen_n_in":null,"score":{"opus":0.1813166460235479,"gpt":0.373956349976804,"spread":0.1926397039532561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001437433,0.00103432,0.004406313,0.0002558894,0.000550944,0.00007139623,0.0001719901,0.0003396629,0.00004834174],"category_scores_gemma":[0.000487356,0.0005494899,0.0004483493,0.0002991372,0.000793028,0.00005592197,0.0003602429,0.001032999,0.00001589782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002037389,"about_ca_system_score_gemma":0.001003227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002920171,"about_ca_topic_score_gemma":0.00001118921,"domain_scores_codex":[0.9946805,0.0009439987,0.002154006,0.0008738971,0.0008502546,0.000497376],"domain_scores_gemma":[0.995383,0.001296681,0.001707541,0.0008322689,0.0003427866,0.00043778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006975096,0.002291888,0.004146323,0.03348304,0.001470042,0.001670032,0.01445469,6.070255e-8,1.977982e-7,0.01586169,0.00972717,0.9161974],"study_design_scores_gemma":[0.004284103,0.0003278063,0.001464675,0.04191181,0.003387068,0.00305573,0.0005334824,0.000001818815,0.00005150974,0.008340019,0.9354799,0.001162077],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007589063,0.9872093,0.00001250278,0.0004172732,0.0004602956,0.003510514,0.00004327322,0.00006065886,0.000697178],"genre_scores_gemma":[0.02351231,0.9735819,0.0002819485,0.00004547503,0.0001867331,0.001857314,0.0004065923,0.00007053748,0.00005722083],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9257528,"threshold_uncertainty_score":0.9996957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766413477","doi":"10.1007/s11899-017-0421-y","title":"Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Social media; Social media analytics; Internet privacy; Field (mathematics); Health care; Categorization; Order (exchange); Analytics; Public relations; Medicine; Computer science; World Wide Web; Data science; Political science; Business","retraction":null,"screen_n_in":null,"score":{"opus":0.414261216503102,"gpt":0.4844890275513483,"spread":0.07022781104824621,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003996682,0.0004021492,0.002994994,0.0008367238,0.001230535,0.00006432968,0.0007386421,0.0005628662,0.00002423275],"category_scores_gemma":[0.02355114,0.0003252162,0.0007883568,0.001772459,0.001071593,0.0001085915,0.0001124968,0.0007836235,7.439914e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005423628,"about_ca_system_score_gemma":0.002793842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008690724,"about_ca_topic_score_gemma":0.005575122,"domain_scores_codex":[0.9943962,0.00178964,0.001743037,0.0005215678,0.001018463,0.0005311563],"domain_scores_gemma":[0.9809796,0.01363887,0.004222663,0.0005972495,0.0004128572,0.0001487889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006010065,0.0006789477,0.01851621,0.02920533,0.0006681706,0.0001195173,0.3632473,7.227959e-7,1.013423e-8,0.005305158,0.00370252,0.578496],"study_design_scores_gemma":[0.0008474909,0.0001031987,0.04270425,0.01401591,0.01202526,0.00001794517,0.02796286,0.000005161074,0.000001127995,0.009236177,0.8916112,0.001469468],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02961769,0.9589528,0.000003037496,0.0006125705,0.005276733,0.004972588,0.0004013699,0.00003112306,0.0001320373],"genre_scores_gemma":[0.1304447,0.8643672,0.00003049546,0.00004213502,0.0007222522,0.003812164,0.000547533,0.00003098479,0.000002482376],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8879086,"threshold_uncertainty_score":0.99992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2483061118","doi":"10.1007/s11899-016-0341-2","title":"Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM","year":2016,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AOP Orphan","keywords":"Social media; Hematologic Neoplasms; Social media analytics; Myeloproliferative neoplasm; Health care; Medicine; Public relations; Interpersonal communication; Internet privacy; Internal medicine; Political science; World Wide Web; Computer science; Sociology; Myelofibrosis; Social science; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.06264256132008802,"gpt":0.3193700999007866,"spread":0.2567275385806985,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003817759,0.0003231227,0.001373458,0.000251854,0.0001849864,0.0000142479,0.0001312587,0.0001417165,0.0002449228],"category_scores_gemma":[0.001138802,0.0001641692,0.0003311872,0.0009102101,0.0002857741,0.00007877261,0.0001570461,0.0002219355,0.000003831554],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006045679,"about_ca_system_score_gemma":0.0001583791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009745039,"about_ca_topic_score_gemma":0.0002396992,"domain_scores_codex":[0.9975984,0.0001685716,0.001018501,0.0004211254,0.0005136917,0.0002797047],"domain_scores_gemma":[0.9962665,0.001658554,0.0009683941,0.000647837,0.0003113736,0.0001473031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001480037,0.000572765,0.9792019,0.0001212909,0.001616819,0.0001198626,0.004986358,8.870686e-7,0.0001874954,0.001669186,0.004042599,0.007332876],"study_design_scores_gemma":[0.003565721,0.0003985479,0.9490213,0.001315314,0.005085305,0.0001646219,0.001367636,0.00001845189,0.02724931,0.00680074,0.004579401,0.0004336722],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912324,0.005132982,0.0002575272,0.002200532,0.0002262921,0.0006266884,0.00008055401,0.0000322736,0.0002107568],"genre_scores_gemma":[0.9975655,0.00136878,0.0006565597,0.00009378436,0.00007036309,0.00008765615,0.00009296132,0.00001728984,0.00004708726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03018058,"threshold_uncertainty_score":0.6694626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2595388903","doi":"10.1007/s11899-017-0368-z","title":"Current Review on High-Risk Multiple Myeloma","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Risk stratification; Disease; Intensive care medicine; Hematology; Internal medicine; Oncology; Risk assessment","retraction":null,"screen_n_in":null,"score":{"opus":0.1741396546027891,"gpt":0.4409754810943322,"spread":0.2668358264915431,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001159309,0.001761357,0.007892954,0.000517216,0.0005554166,0.0001112178,0.0006567528,0.0005604165,0.0005742733],"category_scores_gemma":[0.00583324,0.001124228,0.002513543,0.0003999759,0.0002681769,0.0001292573,0.000470182,0.002101541,0.001433518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004789976,"about_ca_system_score_gemma":0.001310219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003287918,"about_ca_topic_score_gemma":0.000005856988,"domain_scores_codex":[0.9908199,0.0006190381,0.003100209,0.002412973,0.001602688,0.001445243],"domain_scores_gemma":[0.9886177,0.0005041859,0.004748061,0.004726683,0.0003854477,0.001017894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002212465,0.000967336,0.002833709,0.200237,0.0003983217,0.008741729,0.000003485096,1.597038e-8,2.209352e-8,0.00007479423,0.0159522,0.7707693],"study_design_scores_gemma":[0.0006063133,0.0002160422,0.0002959929,0.3276452,0.002569983,0.005102361,5.130697e-7,0.000001280461,0.000002983981,0.0001251946,0.6628249,0.0006092503],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004708542,0.9859229,0.00001499335,0.00006615156,0.003539023,0.008540868,0.000259105,0.0003183134,0.001291555],"genre_scores_gemma":[0.0002349656,0.9930289,0.000134441,0.00002886779,0.0004971189,0.002606226,0.00269358,0.0001653696,0.0006104959],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.77016,"threshold_uncertainty_score":0.9995132,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008063389","doi":"10.1007/s11899-020-00560-x","title":"Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia","year":2020,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Chronic myelogenous leukemia; Medicine; Tyrosine kinase; Hematology; Dasatinib; Toxicity; Internal medicine; Tyrosine-kinase inhibitor; breakpoint cluster region; Imatinib; Leukemia; Cancer research; Pharmacology; Oncology; Receptor; Myeloid leukemia; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04617367194453772,"gpt":0.3129403496724175,"spread":0.2667666777278798,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008624703,0.001316093,0.009900083,0.0006083322,0.00005434729,0.0000113087,0.0003827406,0.0009439024,0.0001687342],"category_scores_gemma":[0.0006374392,0.001052414,0.003259328,0.001430622,0.0002583114,0.00008007404,0.0004415575,0.001030598,0.00002690178],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006269491,"about_ca_system_score_gemma":0.008346957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001414577,"about_ca_topic_score_gemma":0.000009934328,"domain_scores_codex":[0.9912453,0.0003644456,0.004487057,0.001754625,0.001250968,0.0008975959],"domain_scores_gemma":[0.9935765,0.0001555557,0.003265769,0.002387289,0.0002424963,0.000372404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003830755,0.0008339057,0.0002444012,0.2151363,0.00259334,0.02604949,0.0001016948,0.00003162725,0.0002097876,0.0005606301,0.0003913304,0.7538092],"study_design_scores_gemma":[0.003467358,0.001323264,0.00003840426,0.1961394,0.01374001,0.02105406,0.00003323871,0.0000356651,0.01541618,0.001118692,0.7458639,0.001769913],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001632913,0.9920624,0.0002204316,0.00001013146,0.001147104,0.004411581,0.00008409366,0.0001266124,0.0003047424],"genre_scores_gemma":[0.02502425,0.9732759,0.0003847475,0.000006175726,0.0001600593,0.0004662594,0.0005074067,0.0001393039,0.00003588685],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7520393,"threshold_uncertainty_score":0.9999591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014255239","doi":"10.1007/s11899-009-0030-5","title":"Update on the World Health Organization classification of peripheral T-cell lymphomas","year":2009,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoproliferative disorders; Hematology; Medicine; Phenotype; Pathology; Not Otherwise Specified; Oncology; Peripheral T-cell lymphoma; Internal medicine; T cell; Immunology; Biology; Gene; Genetics; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.07503516850817778,"gpt":0.3591512926496702,"spread":0.2841161241414924,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000410666,0.0006099286,0.002461405,0.000239286,0.000155108,0.00003336428,0.0001620683,0.0002011023,0.0003707607],"category_scores_gemma":[0.0001731595,0.00033545,0.0005341946,0.0009565551,0.00007891867,0.00003877607,0.00005078131,0.0002222232,0.00006313045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006900836,"about_ca_system_score_gemma":0.001195289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005495145,"about_ca_topic_score_gemma":0.000002803106,"domain_scores_codex":[0.9961181,0.0002515693,0.001930434,0.0007883079,0.0005221202,0.0003894875],"domain_scores_gemma":[0.9952505,0.0001551985,0.002972506,0.001240866,0.0002112032,0.0001696922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008972374,0.003013204,0.003848764,0.02242384,0.0001586861,0.0005354846,0.00004872501,3.029012e-7,7.426863e-7,0.01409583,0.02695673,0.9289087],"study_design_scores_gemma":[0.0003830218,0.0002141013,0.0008820411,0.03016507,0.0008175374,0.001989272,0.00001048356,0.000001900623,0.00009650151,0.0002648614,0.9648575,0.0003176707],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002625613,0.9927112,0.00001444438,0.0008311091,0.0006467903,0.002552462,0.00001734356,0.000105661,0.00285839],"genre_scores_gemma":[0.009789083,0.9880744,0.00008756568,0.0001773664,0.0001012303,0.00023553,0.001085529,0.00005174712,0.0003975887],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9379008,"threshold_uncertainty_score":0.9999098,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062299904","doi":"10.1007/s11899-011-0100-3","title":"Update: Peripheral T-Cell Lymphomas","year":2011,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Hematology; Peripheral T-cell lymphoma; Oncology; Internal medicine; Disease; T-cell lymphoma; Peripheral; T cell; Pathology; Immunology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.07608571854870042,"gpt":0.3457742507995178,"spread":0.2696885322508173,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002649354,0.001268486,0.004700146,0.0002628756,0.0001424063,0.00005644832,0.0002366135,0.0006741556,0.002178273],"category_scores_gemma":[0.00008434121,0.0008322091,0.001890742,0.0003992846,0.0001387085,0.00008526207,0.0002335022,0.0003632894,0.0006615187],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005868975,"about_ca_system_score_gemma":0.001237906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001485607,"about_ca_topic_score_gemma":0.000001021756,"domain_scores_codex":[0.994744,0.0001464472,0.002215964,0.001562693,0.0004655519,0.0008653309],"domain_scores_gemma":[0.9956842,0.00006618998,0.001789532,0.001805488,0.0001549468,0.0004996114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001141132,0.002749707,0.003479491,0.05304516,0.0003642315,0.02045346,0.00003802469,1.147953e-8,9.6887e-8,0.001484566,0.01627862,0.9020952],"study_design_scores_gemma":[0.0006149976,0.0001433238,0.00004077678,0.0257851,0.003433333,0.03532058,0.000004930795,2.646885e-7,0.00002704867,0.0003186626,0.9335898,0.0007212259],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009275743,0.9762928,0.000008626071,0.00001573084,0.002580801,0.002452415,0.00002929567,0.000315916,0.0182116],"genre_scores_gemma":[0.000599481,0.9953372,0.0003040446,0.00004482912,0.0002434207,0.00129809,0.0009051632,0.000119811,0.001147898],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9173111,"threshold_uncertainty_score":0.9994129,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2913763056","doi":"10.1007/s11899-019-0498-6","title":"Industry’s Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy","year":2019,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"NIH Clinical Center; Novartis Pharmaceuticals Corporation; University of Pennsylvania","keywords":"Chimeric antigen receptor; Medicine; Immunotherapy; Hematology; Cytokine release syndrome; Internal medicine; Clinical trial; Oncology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.09754620024724776,"gpt":0.3758267022807195,"spread":0.2782805020334717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.001612966,0.002023936,0.007019254,0.0009445373,0.0003071552,0.0001811018,0.0009139355,0.003047327,0.008560743],"category_scores_gemma":[0.0001672154,0.001518654,0.002561803,0.001626505,0.0003650018,0.0001873371,0.0004268435,0.005482815,0.001168919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007562988,"about_ca_system_score_gemma":0.002592112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001321401,"about_ca_topic_score_gemma":0.0000020195,"domain_scores_codex":[0.9896409,0.000681273,0.003556119,0.002709475,0.001631668,0.001780561],"domain_scores_gemma":[0.9917237,0.0002703248,0.002986685,0.004008156,0.0003949351,0.0006162602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008501563,0.001028489,0.001506379,0.04072406,0.0007928904,0.00281397,0.0002936474,3.011367e-7,0.004218502,0.00002764845,0.004579313,0.9439298],"study_design_scores_gemma":[0.0009228744,0.0003717445,0.00001716735,0.02365303,0.000471979,0.003932106,0.00004108709,0.000003017016,0.0034841,0.00006927982,0.965584,0.001449595],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002915011,0.9828251,0.00005240909,0.00007509598,0.004060277,0.007373037,0.00002555167,0.0005552865,0.002118239],"genre_scores_gemma":[0.0003698751,0.9890337,0.0002818923,0.00006786306,0.0007002603,0.0007984238,0.001056598,0.0005807885,0.007110611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9610047,"threshold_uncertainty_score":0.9996088,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017131345","doi":"10.1007/s11899-012-0139-9","title":"“Antivirals” in the Treatment of Adult T Cell Leukaemia– Lymphoma (ATLL)","year":2012,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Zidovudine; Lymphoma; Oncology; Immunology; Hematology; Virus; Gastroenterology; Viral disease","retraction":null,"screen_n_in":null,"score":{"opus":0.06301480317142466,"gpt":0.312394578702239,"spread":0.2493797755308143,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000343723,0.0009021739,0.003469842,0.0002489818,0.0001774635,0.00001281091,0.00041567,0.0007739177,0.0001324037],"category_scores_gemma":[0.00005519868,0.0004549112,0.001126508,0.0003873272,0.0003872491,0.00005458319,0.0001243523,0.0003071723,0.0002851907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001579672,"about_ca_system_score_gemma":0.0002277616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007842853,"about_ca_topic_score_gemma":0.00001847525,"domain_scores_codex":[0.9955451,0.0006613127,0.002047959,0.0007805879,0.000114392,0.0008505964],"domain_scores_gemma":[0.9964041,0.0003652982,0.002023072,0.001088162,0.00008921289,0.00003012259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001465712,0.004195331,0.003680077,0.01854191,0.0003744366,0.000692505,0.0009803501,4.130037e-8,0.0000402902,0.0008415448,0.002158444,0.9684804],"study_design_scores_gemma":[0.0004689955,0.0002143257,0.00003865745,0.004717311,0.001223791,0.00277367,0.0001177556,1.482759e-8,0.0008166527,0.0001132464,0.9890276,0.0004880391],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002802474,0.9887553,0.000002380016,0.000009967565,0.00356022,0.001584424,0.00005383635,0.00005937686,0.003172004],"genre_scores_gemma":[0.02229049,0.9757478,0.000008681415,0.000007640526,0.0000787028,0.0005866034,0.0003221567,0.00003639664,0.0009215224],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9868691,"threshold_uncertainty_score":0.9997903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2482129219","doi":"10.1007/s11899-016-0340-3","title":"Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; European Hematology Association","keywords":"Social media; Hematology; The Internet; Hematologic malignancy; Medicine; Cancer; Internal medicine; Family medicine; Computer science; World Wide Web","retraction":null,"screen_n_in":null,"score":{"opus":0.04298612721636083,"gpt":0.3379909896827433,"spread":0.2950048624663825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002829858,0.0009629276,0.003307283,0.0004221909,0.0001973572,0.00008957608,0.000223403,0.0004922099,0.000161035],"category_scores_gemma":[0.001353582,0.0005830492,0.0005137867,0.00027896,0.0004746396,0.00007572761,0.0002500248,0.0004919302,0.00004498868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000246001,"about_ca_system_score_gemma":0.0006619429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001825935,"about_ca_topic_score_gemma":0.000009097111,"domain_scores_codex":[0.9950139,0.0001915132,0.00153469,0.001439291,0.0008722746,0.0009483594],"domain_scores_gemma":[0.996038,0.001330396,0.001184468,0.0005524578,0.0005163822,0.000378302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005890394,0.002266316,0.02041262,0.2231403,0.0007755182,0.005711969,0.001242948,3.182053e-8,0.000001280227,0.0004183408,0.01151541,0.7339262],"study_design_scores_gemma":[0.002653441,0.0006963545,0.000131408,0.05493504,0.001729503,0.01450389,0.00004789932,0.000004122254,0.00001515718,0.0006544254,0.9234837,0.001145047],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01058577,0.9833906,0.00009495806,0.00003354404,0.0006012269,0.004485847,0.0001488247,0.000125869,0.0005333765],"genre_scores_gemma":[0.01472314,0.9818535,0.0001330159,0.00001376346,0.000287821,0.001415973,0.0006405221,0.0001849937,0.0007472603],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9119683,"threshold_uncertainty_score":0.9996621,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2593332867","doi":"10.1007/s11899-017-0372-3","title":"New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Ponatinib; Medicine; Blinatumomab; Internal medicine; Oncology; Philadelphia chromosome; Dasatinib; Imatinib; Hematology; Chemotherapy; Lymphoblastic Leukemia; Leukemia; Chromosomal translocation; Myeloid leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.1141424554496944,"gpt":0.400997813282527,"spread":0.2868553578328326,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002275021,0.002150711,0.007478959,0.0004109638,0.0004584866,0.0002504196,0.0004701571,0.001039124,0.0003436879],"category_scores_gemma":[0.0002433814,0.001494626,0.002737288,0.0002609093,0.0002337214,0.000278991,0.0002196485,0.0004823055,0.0001761119],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008420918,"about_ca_system_score_gemma":0.02278424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007199289,"about_ca_topic_score_gemma":0.000009898168,"domain_scores_codex":[0.9927559,0.0001135147,0.002686489,0.002396166,0.0006708063,0.001377053],"domain_scores_gemma":[0.9917719,0.0003655818,0.003859416,0.002970689,0.0002517368,0.0007807105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009151702,0.0005977214,0.00005195085,0.03880547,0.004338653,0.01773755,0.0001102711,0.00000113837,0.000002505739,0.001061945,0.01092639,0.9262749],"study_design_scores_gemma":[0.002768557,0.001041829,0.00001019019,0.06084457,0.01713732,0.04282511,0.00001569456,0.000009195249,0.000049735,0.001266412,0.8728881,0.001143332],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000468599,0.9851744,0.0007071721,0.00006277907,0.002989222,0.008735799,0.0003386541,0.0003789586,0.001566196],"genre_scores_gemma":[0.0003961046,0.988263,0.0008854234,0.00001389637,0.0009830605,0.002918516,0.003595049,0.000235043,0.002709982],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9251316,"threshold_uncertainty_score":0.9991233,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2767073213","doi":"10.1007/s11899-017-0422-x","title":"Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":15,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Context (archaeology); Medicine; Disease; Cancer; Family medicine; Internal medicine; Computer science; World Wide Web; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.4136773431322619,"gpt":0.4797684941524499,"spread":0.06609115102018803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.002672385,0.000627137,0.004356596,0.001278557,0.001525939,0.00006970246,0.001036849,0.0007335031,0.0001260538],"category_scores_gemma":[0.04065958,0.0005767391,0.001884802,0.002054354,0.0008499201,0.0001272856,0.000187201,0.0008692511,0.000009661886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005155841,"about_ca_system_score_gemma":0.002467075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002975142,"about_ca_topic_score_gemma":0.0006399494,"domain_scores_codex":[0.9929297,0.00154452,0.002696649,0.0007513773,0.001265601,0.0008121824],"domain_scores_gemma":[0.9743905,0.01646667,0.006553065,0.001299626,0.0008162661,0.0004738802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001464824,0.007181172,0.09853524,0.4110733,0.002807046,0.0004412043,0.05058162,0.000007860828,1.187253e-7,0.005991659,0.009505545,0.4137288],"study_design_scores_gemma":[0.0007109547,0.0001568686,0.002701187,0.02946566,0.02923542,0.00001945047,0.003693572,0.0000160469,0.000008914284,0.003952549,0.9282983,0.00174111],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009292415,0.9718217,0.00005373831,0.0001141519,0.01221593,0.005401718,0.0005393592,0.00009068577,0.0004703523],"genre_scores_gemma":[0.08639792,0.908922,0.0001262356,0.000007764475,0.0006607258,0.002963566,0.0008281502,0.00006483989,0.00002878452],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9187927,"threshold_uncertainty_score":0.9997739,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2895867440","doi":"10.1007/s11899-018-0490-6","title":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN—Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Disease; Medicine; Health care; Order (exchange); Political science; Internal medicine; Computer science; Business; World Wide Web","retraction":null,"screen_n_in":null,"score":{"opus":0.09026787319341162,"gpt":0.349614018565047,"spread":0.2593461453716354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008682212,0.0009932452,0.003417885,0.0004166358,0.0003632423,0.00006112042,0.0003442107,0.0006176386,0.0002939808],"category_scores_gemma":[0.0007319619,0.0008584929,0.001232396,0.0006387612,0.0005303872,0.0001155638,0.0002345615,0.001598076,0.00009133933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006174846,"about_ca_system_score_gemma":0.0008926818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002859313,"about_ca_topic_score_gemma":0.00001826258,"domain_scores_codex":[0.9937828,0.001017426,0.002249401,0.001013684,0.001092688,0.0008440178],"domain_scores_gemma":[0.9946535,0.0007846829,0.002716362,0.001176032,0.0002700811,0.0003993636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002477648,0.01476979,0.02217813,0.2631684,0.001780095,0.01692906,0.006288469,0.0000107193,0.00007878727,0.001190583,0.096618,0.5745103],"study_design_scores_gemma":[0.008811344,0.001300174,0.007333769,0.206809,0.01001318,0.00371081,0.000899818,0.00001554745,0.00008320204,0.003587199,0.7531327,0.004303221],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1404743,0.8548023,0.00001884033,0.00002015002,0.002299262,0.001405896,0.0001217013,0.0001558584,0.0007016584],"genre_scores_gemma":[0.3488941,0.6494744,0.00004056391,0.00004243307,0.000441558,0.0001748969,0.0007814217,0.0001094065,0.00004121089],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6565147,"threshold_uncertainty_score":0.9993866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2309364123","doi":"10.1007/s11899-016-0317-2","title":"Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Hematology; Chemotherapy; Hematopoietic cell; Transplantation; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Lymphoblastic Leukemia; Young adult; Acute lymphocytic leukemia; Leukemia; Intensive care medicine; Pediatrics; Haematopoiesis; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.03268983140793776,"gpt":0.3511645003849713,"spread":0.3184746689770336,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006820935,0.001251464,0.004762135,0.0008718675,0.0001137938,0.00004569517,0.0004047482,0.001034017,0.0002018087],"category_scores_gemma":[0.0004642284,0.0008380276,0.001294746,0.0007566029,0.0002121637,0.000148,0.000136851,0.0006222955,0.0002305676],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004048139,"about_ca_system_score_gemma":0.006643557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009250012,"about_ca_topic_score_gemma":0.00000314279,"domain_scores_codex":[0.9921836,0.0001987014,0.003278496,0.001953375,0.0009443805,0.001441492],"domain_scores_gemma":[0.9951135,0.001047055,0.001690652,0.001361386,0.000303626,0.0004837785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004533877,0.0005238486,0.0002654081,0.4708794,0.0004010289,0.02704001,0.0002059777,7.710134e-7,0.000007657714,0.000554132,0.005211154,0.4944572],"study_design_scores_gemma":[0.006557461,0.0005508871,0.00002683032,0.4262953,0.005226037,0.07810441,0.00002286867,0.00006522953,0.0002034286,0.001639081,0.4794571,0.00185133],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004542545,0.9872776,0.002447846,0.00002726958,0.00144768,0.00699769,0.0002040529,0.0002210536,0.0009226073],"genre_scores_gemma":[0.001031933,0.992919,0.0004956124,0.00002057145,0.0002044227,0.003345948,0.001097973,0.0001993404,0.0006852004],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4926059,"threshold_uncertainty_score":0.9997752,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052924000","doi":"10.1007/s11899-007-0022-2","title":"Is BEACOPP better than ABVD?","year":2007,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vincristine; Oncology; Vinblastine; Prednisone; Internal medicine; Cyclophosphamide; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.143285634881988,"gpt":0.417138273985897,"spread":0.2738526391039091,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004336018,0.001180154,0.004530756,0.0004070166,0.0001269442,0.00007526189,0.0001929823,0.0007623023,0.0005542011],"category_scores_gemma":[0.0001139955,0.000763792,0.002034722,0.0004871582,0.0001233726,0.00009910182,0.0001916134,0.0005084653,0.000474897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004271547,"about_ca_system_score_gemma":0.0005947284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001123851,"about_ca_topic_score_gemma":0.000001278317,"domain_scores_codex":[0.9942616,0.00008732635,0.002371928,0.001571039,0.0007831602,0.0009249736],"domain_scores_gemma":[0.9958161,0.0001719354,0.00167124,0.001750041,0.0001621376,0.0004285979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005384261,0.00114354,0.01351673,0.03857718,0.0005092877,0.0255618,0.00002995942,2.432432e-9,6.750819e-8,0.0003316156,0.03159856,0.8887259],"study_design_scores_gemma":[0.0003783811,0.0001129167,0.000215793,0.05484532,0.003185263,0.03046706,0.000003420478,1.114609e-7,0.00004435359,0.0003757732,0.9097459,0.0006256891],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002155964,0.9906241,0.00003115482,0.0001078505,0.002374911,0.002599042,0.00003903417,0.0002396145,0.003768658],"genre_scores_gemma":[0.0002984824,0.9960502,0.0003649493,0.0002377918,0.0004316013,0.0006996829,0.0007153054,0.00010059,0.001101437],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8881002,"threshold_uncertainty_score":0.9994813,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W818882356","doi":"10.1007/s11899-015-0272-3","title":"Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Flow cytometry; Bone marrow; Hematology; International Prognostic Scoring System; Internal medicine; Biopsy; Pathology; Cytology; Oncology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1503424921814746,"gpt":0.4220731153203322,"spread":0.2717306231388577,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003905741,0.0006197383,0.002900116,0.0005877198,0.00005761876,0.00002661803,0.0003689455,0.0004234884,0.000157535],"category_scores_gemma":[0.001800554,0.000318494,0.000469196,0.001263555,0.000143101,0.00008211525,0.0001212732,0.0006863027,0.00002300117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006870999,"about_ca_system_score_gemma":0.0031436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003707253,"about_ca_topic_score_gemma":0.000001813445,"domain_scores_codex":[0.9938928,0.00052499,0.001717359,0.0008891278,0.00238781,0.0005879354],"domain_scores_gemma":[0.9948525,0.0004607347,0.001667933,0.001351399,0.00151429,0.0001531842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001220435,0.001296261,0.01836919,0.08632341,0.0004375117,0.0006166581,0.0003471429,0.00000284643,8.549407e-8,0.00006296099,0.006429023,0.8859929],"study_design_scores_gemma":[0.004816297,0.001310297,0.003310402,0.09504223,0.008648788,0.006424286,0.000167672,0.0005438673,0.000005398946,0.00172435,0.8769748,0.001031652],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004839427,0.9840918,0.00008063438,0.00002566285,0.0003140311,0.009893732,0.0001249401,0.00003176277,0.0005979846],"genre_scores_gemma":[0.02136781,0.9716147,0.0004619579,0.0000206992,0.0001054038,0.00434768,0.001866948,0.0001218427,0.00009300842],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8849612,"threshold_uncertainty_score":0.9999267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766799159","doi":"10.1007/s11899-017-0424-8","title":"Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Dystopia; Hematology; Utopia; Internal medicine; Social media; Medicine; Political science; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.5896881544385401,"gpt":0.5592891715628737,"spread":0.03039898287566634,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004017987,0.0007858941,0.00526775,0.0011469,0.0005119627,0.0001094733,0.001095906,0.002129323,0.0002886387],"category_scores_gemma":[0.01868543,0.0007027179,0.0004473081,0.001331782,0.0007224998,0.0003138705,0.0002314519,0.001795232,0.0001005953],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001586669,"about_ca_system_score_gemma":0.006593056,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001760343,"about_ca_topic_score_gemma":0.037189,"domain_scores_codex":[0.9900013,0.00199619,0.003933358,0.001480024,0.0008826168,0.001706557],"domain_scores_gemma":[0.9902583,0.004489855,0.003848262,0.0009397559,0.0001417274,0.0003221262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005652239,0.0003783151,0.1073808,0.02084915,0.00001894771,0.003959167,0.01511233,2.361452e-8,3.23729e-9,0.01565998,0.0008932922,0.8357423],"study_design_scores_gemma":[0.0002661261,0.00001425654,0.003732471,0.02587355,0.00009218554,0.0002260635,0.0006357962,1.024112e-7,1.348753e-7,0.008212428,0.9601809,0.000765984],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002966798,0.9720477,0.000001022417,0.0004440811,0.01682202,0.005011593,0.00001219148,0.0001098714,0.00258468],"genre_scores_gemma":[0.003834273,0.9890305,0.00004418039,0.00001018445,0.00173813,0.004983484,0.0001427664,0.0000611249,0.0001553948],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9592876,"threshold_uncertainty_score":0.9995424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008576749","doi":"10.1007/s11899-013-0183-0","title":"Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy","year":2013,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Columbia College","funders":"","keywords":"Multiple myeloma; Medicine; Bortezomib; Hematology; Internal medicine; Malignancy; Hematologic malignancy; Intensive care medicine; Clinical trial; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.07505719191943697,"gpt":0.3537867960608366,"spread":0.2787296041413996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000434378,0.001085994,0.00258109,0.0001655778,0.0007536434,0.0001911042,0.0002326578,0.000336861,0.0001213902],"category_scores_gemma":[0.0007535279,0.0004464371,0.0007199268,0.000290532,0.0003346614,0.00009646829,0.0003619587,0.0007776644,0.0001071723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002775725,"about_ca_system_score_gemma":0.0005498707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001284664,"about_ca_topic_score_gemma":0.00001407341,"domain_scores_codex":[0.9948195,0.0005330017,0.00167078,0.001206629,0.0006878591,0.001082274],"domain_scores_gemma":[0.9951028,0.001109022,0.001722325,0.001481288,0.000190544,0.0003940464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001544456,0.0004194795,0.01673598,0.003337613,0.0005550844,0.00189864,0.0001083912,0.00000117696,7.361822e-8,0.0001224384,0.0003756648,0.97643],"study_design_scores_gemma":[0.003094836,0.002612102,0.006026335,0.0232873,0.007043271,0.02173731,0.0002925778,0.0002106709,0.00004165839,0.0002454713,0.933966,0.001442411],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03408786,0.9592628,0.00001294754,0.00003155753,0.0005356842,0.005632632,0.0000844117,0.0001122312,0.0002399004],"genre_scores_gemma":[0.05713697,0.9387055,0.0003013249,0.000009726957,0.0001084858,0.003008354,0.0005240897,0.0000828691,0.0001226548],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9749876,"threshold_uncertainty_score":0.9997987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4309706624","doi":"10.1007/s11899-022-00682-4","title":"The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Oncology; Nausea; Internal medicine; Vomiting","retraction":null,"screen_n_in":null,"score":{"opus":0.07597734830097738,"gpt":0.3604607559086861,"spread":0.2844834076077087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009166665,0.0006070319,0.00267995,0.0003224127,0.000235474,0.00002950008,0.0002452223,0.0002401506,0.000223943],"category_scores_gemma":[0.001323582,0.0003578433,0.0005169575,0.0005369662,0.0002083886,0.00004805622,0.0005012256,0.0008138148,0.00001202489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001796397,"about_ca_system_score_gemma":0.0005687493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005876393,"about_ca_topic_score_gemma":0.00002712215,"domain_scores_codex":[0.9952843,0.0003873654,0.001960475,0.0008957885,0.0007572944,0.0007147867],"domain_scores_gemma":[0.9964181,0.0009466522,0.001240627,0.001049397,0.0000893392,0.0002558853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004785888,0.0004577383,0.03752048,0.01402953,0.0002272183,0.004076027,0.00004410506,5.077808e-8,0.00000123291,0.0001805152,0.0002187066,0.9431965],"study_design_scores_gemma":[0.0007005832,0.0001507008,0.0006655083,0.009146392,0.0004643027,0.01000145,0.00007734504,0.00002173135,0.0000291191,0.0004428533,0.9780016,0.0002984034],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001647175,0.9938067,0.000001320602,0.00002243215,0.0003532266,0.002978052,0.00005598223,0.00005559811,0.001079573],"genre_scores_gemma":[0.005139354,0.9929131,0.00009342584,0.000003594452,0.00005111359,0.001058383,0.0004677467,0.00005753973,0.0002157171],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9777829,"threshold_uncertainty_score":0.9998873,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045989969","doi":"10.1007/s11899-008-0030-x","title":"Novel therapies in peripheral T-cell lymphomas","year":2008,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hematology; Oncology; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Bioinformatics; T cell; Immunology; Biology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.07527003511942738,"gpt":0.3469950288066572,"spread":0.2717249936872299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001691781,0.001084077,0.0043878,0.0003666184,0.000104173,0.0000372095,0.0001762833,0.0005546599,0.0002929422],"category_scores_gemma":[0.00008896111,0.0007205428,0.00134856,0.0005323518,0.0001442381,0.00007449892,0.0001332481,0.0003555676,0.0000776126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007780417,"about_ca_system_score_gemma":0.001238036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003629225,"about_ca_topic_score_gemma":0.000004828343,"domain_scores_codex":[0.995171,0.0001028632,0.002125674,0.001304173,0.0005454294,0.0007508686],"domain_scores_gemma":[0.9970626,0.000132471,0.001271028,0.001182094,0.00009564712,0.0002561234],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001515314,0.00644659,0.01960189,0.03548032,0.0003099132,0.03544865,0.0002092512,2.176542e-7,0.000001358394,0.0003434771,0.003953746,0.8981894],"study_design_scores_gemma":[0.001217622,0.0001179829,0.0003727024,0.03047047,0.0005629617,0.06489637,0.00001443718,9.309357e-7,0.00001612736,0.00007054565,0.901632,0.0006278414],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006682365,0.9909198,0.000008903094,0.00002959581,0.001318239,0.002385221,0.00002030594,0.0001624864,0.004487175],"genre_scores_gemma":[0.00171603,0.9954708,0.0003507455,0.00003332605,0.0001547748,0.001313294,0.0003867809,0.00008953475,0.0004847026],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8976783,"threshold_uncertainty_score":0.9995246,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007505304","doi":"10.1007/s11899-014-0213-6","title":"Which Hodgkin’s Patients in the Unites States Should Be Treated with BEACOPP?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Medicine; Procarbazine; Dacarbazine; Vinblastine; Oncology; Internal medicine; Hodgkin's lymphoma; Regimen; Vincristine; Chemotherapy; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.03486173526679406,"gpt":0.2923363232740295,"spread":0.2574745880072354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003612668,0.0003536609,0.0006076245,0.0001326256,0.0001030844,0.000041889,0.0001073985,0.0001053504,0.00007247883],"category_scores_gemma":[0.0002359878,0.0001757915,0.00009180204,0.0005212029,0.00007614406,0.00007519158,0.00004184508,0.0001688223,0.00001168824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009580651,"about_ca_system_score_gemma":0.00007805063,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001398171,"about_ca_topic_score_gemma":0.000124905,"domain_scores_codex":[0.9976724,0.0001478877,0.0006385483,0.0005620522,0.0005335477,0.0004456016],"domain_scores_gemma":[0.9983744,0.0002187005,0.000351643,0.0007172462,0.0002102749,0.0001277088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004968443,0.002039309,0.9900486,0.0001684953,0.00004647794,0.0006543185,0.0003182858,0.000004335351,0.000003721285,0.0005325662,0.004202674,0.001931528],"study_design_scores_gemma":[0.003244143,0.001206261,0.969393,0.001200857,0.0003341622,0.001603554,0.0002102628,0.0000654297,0.002056725,0.0007435111,0.01954962,0.0003924847],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928998,0.001176165,0.00001202125,0.001190065,0.0001319845,0.001097111,0.000008758903,0.00009595973,0.003388106],"genre_scores_gemma":[0.9982179,0.0003252753,0.00009313742,0.0003669881,0.00003147387,0.0003742669,0.0005171256,0.00002158929,0.00005226268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02065561,"threshold_uncertainty_score":0.7168571,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415987224","doi":"10.1007/s11899-025-00764-z","title":"Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Blinatumomab; Chimeric antigen receptor; Ponatinib; Immunotherapy; Hematology; Minimal residual disease; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.03765103770373049,"gpt":0.3498580066873185,"spread":0.312206968983588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000672852,0.0008997026,0.00402076,0.0003203642,0.0002108207,0.00003801097,0.0003727034,0.0003412396,0.0002062726],"category_scores_gemma":[0.00004872687,0.0004173325,0.001269763,0.0007245983,0.000726948,0.00004665924,0.0000897747,0.000457543,0.000003503768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003170577,"about_ca_system_score_gemma":0.001863143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001045744,"about_ca_topic_score_gemma":0.000006204569,"domain_scores_codex":[0.9951918,0.000358428,0.00217328,0.0009238583,0.0007131418,0.0006395133],"domain_scores_gemma":[0.9955406,0.0009655469,0.001439465,0.001654414,0.0002609189,0.0001390772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001274909,0.0008939296,0.001807809,0.03350149,0.001559411,0.0008658121,0.0007905782,3.302289e-7,0.001315801,0.0003784196,0.0002369252,0.958522],"study_design_scores_gemma":[0.001088855,0.0005340044,0.00001883434,0.02311883,0.003172744,0.003965049,0.0001816943,0.000006786236,0.00903216,0.0002948041,0.9581923,0.0003938668],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007804587,0.9844903,0.00001163346,0.00003511904,0.000578867,0.005490069,0.0001031642,0.00006794999,0.001418289],"genre_scores_gemma":[0.00560227,0.9925035,0.00001839342,0.000006822223,0.00009012566,0.0003845775,0.0002023366,0.00007770446,0.00111427],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9581282,"threshold_uncertainty_score":0.9998279,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2191051211","doi":"10.1007/s11899-015-0296-8","title":"Myelofibrosis—When Do We Select Transplantation or Non-transplantation Therapeutic Options?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Transplantation; Ruxolitinib; Hematology; Internal medicine; Hematopoietic stem cell transplantation; Janus kinase; Oncology; Intensive care medicine; Disease; Bone marrow","retraction":null,"screen_n_in":null,"score":{"opus":0.1169405602821958,"gpt":0.3937964703190582,"spread":0.2768559100368624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005667149,0.001180139,0.003601944,0.0004516564,0.0002030155,0.0001081665,0.0001694759,0.0006272614,0.0005444858],"category_scores_gemma":[0.00005801781,0.0007368177,0.0008554251,0.0005956972,0.0001010942,0.0001769519,0.00002900404,0.0005861571,0.0001725342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003800474,"about_ca_system_score_gemma":0.001459809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008845629,"about_ca_topic_score_gemma":0.000008624706,"domain_scores_codex":[0.9944998,0.0003347655,0.002200875,0.001410193,0.0008724417,0.0006819441],"domain_scores_gemma":[0.9966295,0.0002822543,0.001443238,0.0008639542,0.0003855003,0.0003956017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002049896,0.00131263,0.001501302,0.09944886,0.0009691918,0.009335808,0.0006921481,0.000001367652,0.000002831888,0.0007446458,0.004168966,0.8816172],"study_design_scores_gemma":[0.001278064,0.0006844918,0.0001361771,0.07181492,0.01015156,0.04668242,0.00002482226,0.000005889658,0.000131348,0.001184132,0.8669295,0.0009766408],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001693376,0.9918815,0.0006327026,0.0001291195,0.001212717,0.004879293,0.0001465651,0.0002345063,0.0007142393],"genre_scores_gemma":[0.0007703012,0.9919881,0.0009432287,0.00003143169,0.0002288204,0.002644059,0.002840402,0.0001139919,0.0004396558],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8806406,"threshold_uncertainty_score":0.9995083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4376641118","doi":"10.1007/s11899-023-00698-4","title":"A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment","year":2023,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Hematology; Oncology; Internal medicine; Population; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0647491682968343,"gpt":0.36325252237516,"spread":0.2985033540783257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006529163,0.002046718,0.007139093,0.001435888,0.0001387941,0.00005486443,0.0004041932,0.0007637815,0.00007617193],"category_scores_gemma":[0.0004242224,0.001512522,0.001551448,0.001958446,0.0001141884,0.000125447,0.0004557926,0.0009526395,0.0008778393],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02843538,"about_ca_system_score_gemma":0.006083177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006327074,"about_ca_topic_score_gemma":0.00003552903,"domain_scores_codex":[0.9907652,0.0004023384,0.003331102,0.002809402,0.0009269122,0.001765119],"domain_scores_gemma":[0.9942473,0.0004228564,0.001810455,0.002722731,0.0000811493,0.0007155654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00002234215,0.0009978533,0.002451948,0.3212997,0.0009946736,0.04620298,0.0002028265,0.00002498568,9.52008e-7,0.0001674393,0.0005363067,0.627098],"study_design_scores_gemma":[0.007337367,0.00159624,0.001927916,0.6399831,0.01310567,0.05539084,0.00004165125,0.0001865773,0.00002953589,0.0004216474,0.2761008,0.003878731],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001770879,0.9780341,0.0001388707,0.00001592743,0.001550375,0.01582302,0.00002111407,0.0007047973,0.001940896],"genre_scores_gemma":[0.0006339905,0.9847918,0.0004576086,0.00001775235,0.0003421655,0.01003513,0.001766448,0.0003177743,0.001637331],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6232193,"threshold_uncertainty_score":0.9999001,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2022946612","doi":"10.1007/s11899-014-0214-5","title":"Chemotherapy Only in Early Stage Hodgkin Lymphoma: More Relapses but the Same Survival – What to Do?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"ABVD; Medicine; Lymphoma; Stage (stratigraphy); Hodgkin's lymphoma; Chemotherapy; Radiation therapy; Hodgkin lymphoma; Internal medicine; Dacarbazine; Randomized controlled trial; Survival rate; Positron emission tomography; Oncology; Surgery; Radiology; Vincristine; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.02428622731474941,"gpt":0.3011997911824983,"spread":0.2769135638677489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007099257,0.0004678371,0.0009441758,0.0001610804,0.0001239475,0.0001566663,0.0001956171,0.0001675346,0.0001403145],"category_scores_gemma":[0.0003402293,0.0002851472,0.0002629721,0.0004158383,0.0001060371,0.0001949751,0.0001180001,0.0001424455,0.00007452319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002397737,"about_ca_system_score_gemma":0.000235548,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002385937,"about_ca_topic_score_gemma":0.00005084208,"domain_scores_codex":[0.9967336,0.0001543374,0.0009423774,0.0008815321,0.0006421818,0.0006459935],"domain_scores_gemma":[0.9977357,0.0002185386,0.0004142667,0.001232802,0.0001259941,0.0002727443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001152083,0.001615285,0.909737,0.0002002795,0.00007548851,0.002608219,0.001265261,0.000004199074,0.00004501739,0.003066776,0.00168332,0.07958399],"study_design_scores_gemma":[0.003689071,0.0005382037,0.9401551,0.002182767,0.0001183656,0.002925023,0.00129293,0.00001879003,0.004854664,0.001539633,0.04209837,0.0005870974],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838459,0.008438315,0.00005533407,0.003495625,0.001583238,0.001411722,0.000006467817,0.0001225244,0.001040864],"genre_scores_gemma":[0.9959638,0.002004833,0.0001820972,0.0007923173,0.0001388492,0.0002404796,0.00003370401,0.00004222819,0.0006016757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07899689,"threshold_uncertainty_score":0.9999601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402312879","doi":"10.1007/s11899-024-00742-x","title":"Advances in Stem Cell Transplantation for Myelofibrosis","year":2024,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Transplantation; Hematology; Stem cell; Internal medicine; Oncology; Intensive care medicine; Biology; Bone marrow; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.06258721104371225,"gpt":0.3826865452418554,"spread":0.3200993341981431,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002867092,0.0008054985,0.00314434,0.0004027188,0.00006512912,0.00004626353,0.00008875065,0.0003677018,0.00005238172],"category_scores_gemma":[0.00002632056,0.0005228313,0.0009828836,0.0004456417,0.00004558665,0.0001108932,0.00003205907,0.0003650797,0.00006069422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002369156,"about_ca_system_score_gemma":0.0004365642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001681697,"about_ca_topic_score_gemma":0.000006572744,"domain_scores_codex":[0.9959655,0.00009178255,0.001873551,0.001227522,0.0003407157,0.0005009595],"domain_scores_gemma":[0.9981958,0.000255133,0.0007974488,0.000494917,0.0000959568,0.0001607161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001885714,0.0004652299,0.0008123922,0.2674589,0.00006924404,0.004086014,0.00007997743,2.798492e-7,2.090432e-7,0.0006718378,0.000805203,0.7255319],"study_design_scores_gemma":[0.0003976682,0.0002301213,0.00001582343,0.1011201,0.003691286,0.005273693,0.0000148048,0.000002720753,0.00009067977,0.0005207482,0.8881725,0.0004698425],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009298301,0.9912181,0.0001341672,0.00003168032,0.001640487,0.005146515,0.0001315175,0.0001336702,0.00147083],"genre_scores_gemma":[0.0005580872,0.991609,0.0003022418,0.00001050977,0.0001242355,0.005950626,0.001056122,0.00008039326,0.0003087699],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8873673,"threshold_uncertainty_score":0.9997223,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413100643","doi":"10.1007/s11899-025-00754-1","title":"Allogeneic Transplant for CMML","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematology; Internal medicine; Oncology; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09515401914913654,"gpt":0.4224962066267783,"spread":0.3273421874776418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008483907,0.0009990777,0.005081754,0.0006327694,0.0001579543,0.0000409857,0.000393202,0.0008902038,0.000222902],"category_scores_gemma":[0.0008296234,0.000703912,0.002093485,0.0007032195,0.0001480364,0.00004863843,0.0001719064,0.0009612416,0.00007585715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004871808,"about_ca_system_score_gemma":0.004050045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002849396,"about_ca_topic_score_gemma":0.000001350147,"domain_scores_codex":[0.994183,0.0001727628,0.002367443,0.001617614,0.0005780633,0.001081143],"domain_scores_gemma":[0.9960625,0.0006263771,0.00101271,0.001630089,0.000299312,0.0003690794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002659335,0.0002566384,0.0001416736,0.3063121,0.0003847655,0.005350171,0.00001475004,3.787989e-8,0.000001118562,0.0008182345,0.03745842,0.6492355],"study_design_scores_gemma":[0.000392596,0.0001045342,0.000002109037,0.09573487,0.00296911,0.0169901,0.000002597923,0.000002021729,0.00002521039,0.0004645587,0.8827888,0.0005235142],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006335392,0.9866143,0.0008896386,0.00008905473,0.001912605,0.007446067,0.000218985,0.0002786279,0.00254433],"genre_scores_gemma":[0.00001948432,0.9883959,0.0006437455,0.00004857144,0.0002840109,0.003571903,0.002562043,0.00009707207,0.00437728],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8453304,"threshold_uncertainty_score":0.9995412,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}